Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy, Adjuvant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Testing effectiveness (Phase 2)Looking for participantsNCT05726370
What this trial is testing

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 28
Large-scale testing (Phase 3)Study completedNCT02251977
What this trial is testing

Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer

Who this might be right for
Colorectal CancerChemotherapy-induced Neutropenia
Yuhong Li 196
Not applicableUnknownNCT03156777
What this trial is testing

Application Value of CTCs Detection for Advanced Gastric Cancer Patients

Who this might be right for
Circulating Tumor CellsGastric Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 200
Testing effectiveness (Phase 2)WithdrawnNCT04030000
What this trial is testing

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Who this might be right for
Uterine Carcinoma
Northwell Health
Not applicableUnknownNCT02041364
What this trial is testing

Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer

Who this might be right for
FatigueBreast Cancer
Faculdade de Medicina do ABC 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04723875
What this trial is testing

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Who this might be right for
Uterine Cervical NeoplasmsCervical Cancer
Huazhong University of Science and Technology 306
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Testing effectiveness (Phase 2)UnknownNCT00923637
What this trial is testing

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 75
Large-scale testing (Phase 3)Ended earlyNCT00863512
What this trial is testing

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Looking for participantsNCT07788196
What this trial is testing

A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression.

Who this might be right for
IB-II Gastric Cancer
Xijing Hospital 120
Not applicableNot Yet RecruitingNCT04451369
What this trial is testing

Connected Prehabilitation Program During Neo Adjuvant Chemotherapy

Who this might be right for
Ovarian Cancer
Institut Paoli-Calmettes 136
Not applicableStudy completedNCT01331772
What this trial is testing

Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy

Who this might be right for
Breast CancerAdequate Physical Condition
Centre Leon Berard 60
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Not applicableUnknownNCT03983811
What this trial is testing

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Nanfang Hospital, Southern Medical University 174
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
Women's Cancer Study Group GmbH 1,684
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Not applicableUnknownNCT03277898
What this trial is testing

Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer

Who this might be right for
Breast Neoplasms
University of British Columbia 84
Not applicableUnknownNCT02075957
What this trial is testing

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Angers 192
Next Page